Factors Associated with the Effects of Ipragliflozin on the Diurnal Profiles of Plasma Glucose and 3-hydroxybutyrate in Patients with Type 2 Diabetes

被引：0
|
作者：
Nakayama, Hitomi
Yoshinobu, Satoko
Kawano, Seiko
Tsuruta, Munehisa
Nohara, Masayuki
Hasuo, Rika
Akasu, Shoko
Tokubuchi, Ichiro
Wada, Nobuhiko
Hirao, Saori
Iwata, Shinpei
Kaku, Hiroo
Otabe, Shuichi
Tajiri, Yuji
Yamada, Kentaro
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1236-P
引用
收藏
页码：A320 / A320
页数：1
相关论文
共 50 条
  • [31] Factors associated with depression in the patients with diabetes mellitus type 2
    Sabanovic, Admir
    Maksimovic, Natasa
    Stojanovic-Tasic, Mirjana
    Bakic, Marijan
    Grgurevic, Anita
    VOJNOSANITETSKI PREGLED, 2019, 76 (11) : 1178 - 1183
  • [32] Level of stigma and associated factors in patients with type 2 diabetes
    Kong, Y.
    Zhou, H.
    Cheng, L.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [33] Efficacy and safety of sodium-glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus; Fukuoka Study of Ipragliflozin (FUSION)
    Nomiyama, Takashi
    Shimono, Dai
    Horikawa, Tsuyoshi
    Fujimura, Yuki
    Ohsako, Tomohiro
    Terawaki, Yuichi
    Fukuda, Takashi
    Motonaga, Ryoko
    Tanabe, Makito
    Yanase, Toshihiko
    Nawata, Hajime
    Takahashi, Hiroyuki
    Yanagida, Ikumi
    Ono, Junko
    Kogawa, Kazuhiko
    Muta, Kazuo
    Arase, Koichi
    Oba, Koichi
    Murase, Kunitaka
    Hamanoue, Nobuya
    Minezaki, Midori
    Imamura, Mitsuhide
    Yoshida, Ryoko
    Yatabe, Sakon
    Komatsu, Shiho
    Maruyama, Syunichiro
    Futata, Tetsuhiro
    Umei, Toshihiko
    Noda, Tomohiro
    Hyodo, Tomoko
    Tsutsumi, Yoko
    Takeda, Yumi
    Hatta, Yumiko
    Fukuda, Yusuke
    Fujihara, Yuya
    ENDOCRINE JOURNAL, 2018, 65 (08) : 859 - 867
  • [34] Modeling of 24-Hour Glucose and Insulin Profiles of Patients With Type 2 Diabetes
    Jauslin, Petra M.
    Frey, Nicolas
    Karlsson, Mats O.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (02): : 153 - 164
  • [35] Are Circulating Mg2+ Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes?
    Spiga, Rosangela
    Mannino, Gaia Chiara
    Mancuso, Elettra
    Averta, Carolina
    Paone, Claudia
    Rubino, Mariangela
    Sciacqua, Angela
    Succurro, Elena
    Perticone, Francesco
    Andreozzi, Francesco
    Sesti, Giorgio
    NUTRIENTS, 2019, 11 (10)
  • [36] Associations of Plasma Concentration Profiles of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-Transporter Type 2, with Its Effects in Japanese Patients with Type 2 Diabetes Mellitus
    Hayakawa, Tetsuo
    Kato, Ken-Ichiro
    Kobuchi, Shinji
    Kataoka, Kaede
    Sakaeda, Toshiyuki
    PHARMACEUTICALS, 2022, 15 (02)
  • [37] Effect of weight loss on plasma lipids and glucose in patients with type 2 diabetes
    Faghih, Shiva
    Ansari, Negin
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S106 - S106
  • [38] Variation of Fasting Plasma Glucose: A Predictor of Mortality in Patients with Type 2 Diabetes
    Lin, Cheng-Chieh
    Li, Chia-Ing
    Yang, Sing-Yu
    Liu, Chiu-Shong
    Chen, Ching-Chu
    Fuh, Martin Mao-Tsu
    Chen, Walter
    Li, Tsai-Chung
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (04): : 416.e9 - 416.e18
  • [39] Genetic Variants Associated with Lipid Profiles in Chinese Patients with Type 2 Diabetes
    Kong, Xiaomu
    Zhao, Qi
    Xing, Xiaoyan
    Zhang, Bo
    Zhang, Xuelian
    Hong, Jing
    Yang, Wenying
    PLOS ONE, 2015, 10 (08):
  • [40] The effects of pitavastatin on glucose metabolism in patients with type 2 diabetes with hypercholesterolemia
    Daido, Hisashi
    Horikawa, Yukio
    Takeda, Jun
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (03) : 531 - 537
12345